Elixinol Wellness Limited (EXL.AX)
AUD 0.04
(-7.5%)
AUD 0.04
(-7.5%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.26 Million AUD | -31.23% |
| 2022 | 1.83 Million AUD | -30.7% |
| 2021 | 2.64 Million AUD | -0.15% |
| 2020 | 2.65 Million AUD | -42.72% |
| 2019 | 4.63 Million AUD | 1752.0% |
| 2018 | 250 Thousand AUD | -13.19% |
| 2017 | 288 Thousand AUD | -58.97% |
| 2016 | 702 Thousand AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 883 Thousand AUD | 0.0% |
| 2023 Q2 | 1.28 Million AUD | 0.0% |
| 2023 Q4 | 1.26 Million AUD | 0.0% |
| 2023 FY | 1.26 Million AUD | -31.23% |
| 2022 Q2 | 2.08 Million AUD | 0.0% |
| 2022 Q4 | 1.83 Million AUD | 0.0% |
| 2022 FY | 1.83 Million AUD | -30.7% |
| 2021 Q2 | 2.69 Million AUD | 0.0% |
| 2021 FY | 2.64 Million AUD | -0.15% |
| 2021 Q4 | 2.64 Million AUD | 0.0% |
| 2020 Q2 | 3.54 Million AUD | 0.0% |
| 2020 Q4 | 2.65 Million AUD | 0.0% |
| 2020 FY | 2.65 Million AUD | -42.72% |
| 2019 Q4 | 4.63 Million AUD | 0.0% |
| 2019 Q2 | 4.65 Million AUD | 0.0% |
| 2019 FY | 4.63 Million AUD | 1752.0% |
| 2018 Q4 | 250 Thousand AUD | 0.0% |
| 2018 Q2 | 250 Thousand AUD | 0.0% |
| 2018 FY | 250 Thousand AUD | -13.19% |
| 2017 FY | 288 Thousand AUD | -58.97% |
| 2016 FY | 702 Thousand AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Althea Group Holdings Limited | 972 Thousand AUD | -29.835% |
| Cann Group Limited | 72.46 Million AUD | 98.258% |
| ECS Botanics Holdings Ltd | 1.02 Million AUD | -23.256% |
| Ecofibre Limited | 25.49 Million AUD | 95.05% |
| Hygrovest Limited | - AUD | -Infinity% |
| IDT Australia Limited | 4.46 Million AUD | 71.755% |
| Invion Limited | - AUD | -Infinity% |
| Little Green Pharma Ltd | 11.86 Million AUD | 89.366% |
| Live Verdure Ltd | 22.29 Thousand AUD | -5561.732% |
| Medical Developments International Limited | 2.28 Million AUD | 44.794% |
| Vitura Health Limited | 5.31 Million AUD | 76.273% |
| Vita Life Sciences Limited | 387 Thousand AUD | -226.098% |